Zobrazeno 1 - 10
of 678
pro vyhledávání: '"Myron J Levin"'
Autor:
Myron J. Levin, Victoria Divino, Maarten J. Postma, Stephen I. Pelton, Zifan Zhou, Mitch DeKoven, Joaquin Mould-Quevedo
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 124-136 (2024)
ABSTRACTBackground Clinical evidence supports use of enhanced influenza vaccines in older adults. Few economic outcome studies have compared adjuvanted trivalent inactivated (aIIV3) and standard egg-derived quadrivalent inactivated influenza vaccines
Externí odkaz:
https://doaj.org/article/e53c478a9aef4f41a22846665211f28e
Autor:
Myron J. Levin, Andrew Ustianowski, Stephane De Wit, Rohini Beavon, Jesse Thissen, Seth Seegobin, Kanika Dey, Karen A. Near, Katie Streicher, Alexandre Kiazand, Mark T. Esser
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 6, Pp 1253-1268 (2024)
Abstract Introduction The phase 3 PROVENT and STORM CHASER studies evaluated AZD7442 (tixagevimab/cilgavimab) for pre-exposure and post-exposure prophylaxis of symptomatic coronavirus disease 2019 (COVID-19). We report the final 15-month results of b
Externí odkaz:
https://doaj.org/article/a0dc96dc6a4541d2935ee2e82a120a9f
Autor:
David Fisman, Norberto Giglio, Myron J. Levin, Van Hung Nguyen, Stephen I. Pelton, Maarten Postma, Jesús Ruiz-Aragón, Analia Urueña, Joaquin F. Mould-Quevedo
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
Seasonal influenza significantly affects both health and economic costs in children and adults. This narrative review summarizes published cost-effectiveness analyses (CEAs) of cell-based influenza vaccines in children and adults
Externí odkaz:
https://doaj.org/article/46ed3c1277e545b39589949ace3de340
Autor:
Seong Yeon Park, Myron J. Levin, Jennifer Canniff, Michael Johnson, D. Scott Schmid, Adriana Weinberg
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-7 (2022)
Abstract Zoster vaccines generate antibody responses against varicella-zoster virus (VZV). We compared antibody-dependent cell cytotoxicity (ADCC) elicited by zoster vaccine live (ZVL) and recombinant zoster vaccine (RZV). ADCC mediated by antibodies
Externí odkaz:
https://doaj.org/article/27b0ac31045f491baf6ed953c6c7bd36
Autor:
Romulo Colindres, Valentine Wascotte, Alain Brecx, Christopher Clarke, Caroline Hervé, Joon Hyung Kim, Myron J. Levin, Lidia Oostvogels, Toufik Zahaf, Anne Schuind, Anthony L. Cunningham
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 11, Pp 2628-2633 (2020)
In two large clinical trials (ZOE-50 [NCT01165177] and ZOE-70 [NCT01165229]), two doses of the adjuvanted recombinant zoster vaccine (RZV) demonstrated >90% efficacy against herpes zoster in adults ≥50 years of age. Solicited adverse events (AEs) w
Externí odkaz:
https://doaj.org/article/a426b076a4c9441b8ceb65db156795c0
Autor:
Desmond Curran, Melissa K. Andrew, Myron J. Levin, Elisa Turriani, Sean Matthews, Charles Fogarty, Nicola P. Klein, Katrijn Grupping, Lidia Oostvogels, Kenneth E. Schmader
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 12, Pp 2960-2968 (2019)
Frail older adults are at increased risk of poor clinical outcomes. Frailty assessment is therefore important in clinical trials to understand the benefits and harms of interventions. However, consensus is lacking on how frailty should be assessed. W
Externí odkaz:
https://doaj.org/article/56287ad8fafd48bbab247f31b6a0ae1b
Autor:
Lidia Oostvogels, Thomas C. Heineman, Robert W. Johnson, Myron J. Levin, Janet E. McElhaney, Peter Van den Steen, Toufik Zahaf, Alemnew F. Dagnew, Roman Chlibek, Javier Diez-Domingo, Iris S. Gorfinkel, Caroline Hervé, Shinn-Jang Hwang, Hideyuki Ikematsu, George Kalema, Himal Lal, Shelly A. McNeil, Tomas Mrkvan, Karlis Pauksens, Jan Smetana, Daisuke Watanabe, Lily Yin Weckx, Anthony L. Cunningham
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 12, Pp 2865-2872 (2019)
In two pivotal efficacy studies (ZOE-50; ZOE-70), the adjuvanted recombinant zoster vaccine (RZV) demonstrated >90% efficacy against herpes zoster (HZ). Adults aged ≥50 or ≥70 years (ZOE-50 [NCT01165177]; ZOE-70 [NCT01165229]) were randomized to
Externí odkaz:
https://doaj.org/article/2de77cc0739443df82239135c7c026b5
Autor:
Adriana Weinberg, Stacie L Lambert, Jennifer Canniff, Li Yu, Nancy Lang, Mark T Esser, Judith Falloon, Myron J Levin
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 10, Pp 2466-2474 (2019)
Background: Infections with respiratory syncytial virus (RSV) cause significant morbidity and hospitalization in older adults. We studied the humoral, mucosal and B cell responses of an investigational adjuvanted RSV sF vaccine, MEDI7510, in older ad
Externí odkaz:
https://doaj.org/article/8ee7ccb20b7f42a1b450016580d134ea
Autor:
Myron J Levin, Adriana Weinberg
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 4, Pp 772-777 (2019)
There are two licensed herpes zoster vaccines. One is a live vaccine (ZVL) based on an attenuated varicella-zoster virus (VZV). The other is a recombinant vaccine (RZV) based on the VZV glycoprotein E (gE) combined with AS01B, a multicomponent adjuva
Externí odkaz:
https://doaj.org/article/0d0a05386b084da3a5463b9c8b0db484
Autor:
Marian Krawczyński
Publikováno v:
Pediatria Polska. 87:230
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b80f8d3d3f5a37e4065ecc3759212a8
https://doi.org/10.1016/s0031-3939(12)70621-2
https://doi.org/10.1016/s0031-3939(12)70621-2